Single-Use Bioprocessing Market

Table of Contents

Growth of the Single-Use Bioprocessing Market

The global single-use bioprocessing market is expected to grow from USD 20.96 billion in 2022 to USD 84.14 billion by 2032, driven by a CAGR of 15.46%. This growth is fueled by increasing demand for personalized medicines, rising R&D investments, and the adoption of decentralized clinical trials.

Single-Use Bioprocessing Market Size 2023 - 2032

Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5030

Growth and Challenges in the Single-Use Bioprocessing Market

The single-use bioprocessing market is a rapidly expanding segment of the biopharmaceutical industry. This approach uses disposable, single-use equipment instead of traditional stainless-steel systems for manufacturing biopharmaceuticals. It offers several key benefits, including a reduced risk of contamination, faster setup times, and greater flexibility. These advantages are driving the growth of the market, alongside rising demand for biologics, the growing biopharmaceutical sector, and the clear benefits of single-use methods over traditional manufacturing.

Biologics, which are complex molecules produced using living cells, are used to treat a wide range of diseases, including cancer, autoimmune disorders, and infections. As demand for biologics increases, single-use bioprocessing becomes an ideal solution due to its ability to efficiently produce these intricate molecules. North America is expected to lead the single-use bioprocessing market, followed by Europe and Asia Pacific, due to the presence of major biopharmaceutical companies and supportive government policies.

However, the market faces some challenges, including concerns over the quality and consistency of single-use products, a lack of industry-wide standardization, and the high costs of single-use equipment. These issues are being addressed through technological innovations, efforts to standardize processes, and growing competition within the market.

Key Companies in the Single-Use Bioprocessing Market

The single-use bioprocessing market is supported by several leading companies that specialize in providing innovative solutions for biopharmaceutical manufacturing. Notable players in the market include:

Thermo Fisher Scientific, Inc.: A global leader in laboratory supplies, Thermo Fisher offers a wide range of single-use bioprocessing products designed to enhance efficiency and flexibility in biomanufacturing.
Sartorius AG: Known for its cutting-edge bioprocessing technologies, Sartorius provides single-use equipment that improves the production of biologics, focusing on scalability and innovation.
Merck KGaA: This global science and technology company offers a comprehensive portfolio for single-use bioprocessing, supporting the development and manufacturing of biologics.
Pall Corporation: Specializing in filtration and separation technologies, Pall offers single-use products that are crucial for ensuring purity and efficiency in biopharmaceutical production.
Corning Incorporated: Corning provides innovative solutions for single-use bioprocessing, with a focus on cell culture, filtration, and bioreactor technologies.
Eppendorf AG: Eppendorf develops high-quality single-use bioprocessing products for the biopharmaceutical industry, particularly in the areas of cell culture and protein production.
General Electric Company (GE Healthcare): GE Healthcare provides advanced single-use technologies that enhance biomanufacturing processes, helping companies increase efficiency and reduce costs.
Lonza: A global leader in biological manufacturing, Lonza offers single-use solutions that support the production of biologics and biosimilars, as well as cell and gene therapies.
Rentschler Biopharma SE: Specializing in contract manufacturing, Rentschler Biopharma provides single-use bioprocessing services that are tailored to meet the growing demand for biologics.
JM BioConnect: JM BioConnect offers single-use technologies that improve the flexibility and scalability of biopharmaceutical production.
Meissner Filtration Products, Inc.: A key player in filtration and purification technologies, Meissner supplies single-use products that ensure high-quality biomanufacturing processes.
Infors AG: Infors specializes in bioreactor systems and other single-use technologies that optimize bioprocessing for the production of biologics.
Boehringer Ingelheim GmbH: A major pharmaceutical company, Boehringer Ingelheim provides single-use solutions designed to enhance the production of biologics, especially in large-scale manufacturing.
Entegris, Inc.: Entegris offers filtration and purification technologies that are essential for single-use bioprocessing, helping companies streamline production and ensure product quality.
PBS Biotech, Inc.: PBS Biotech focuses on providing single-use bioreactors and related technologies that enable more efficient and flexible biomanufacturing.